Guangdong Marubi Biotechnology Co. Ltd Financials

Market Capitalization CN¥13.47 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	38.55
Forward PE	25.50
Price to Sales TTM	CN¥3.83
Price to Book MRQ	CN¥4.00
Enterprise to Revenue	3.43
Enterprise to EBITDA	33.74

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	10.00%
Operating Margin	4.00%
Return on Assets TTM	4.40%
Return on Equity TTM	10.22%

Income Statement

Revenue TTM	CN¥3,467,816,704
Revenue per Share TTM	CN¥8.60
Quarterly Revenue Growth	13.50%
Gross Profit TTM	CN¥2,555,185,152
EBITDA	CN¥414,713,926
Net Income to Common TTM	CN¥346,717,696
Diluted EPS TTM	CN¥0.86
Quarterly Earnings Growth YoY	-6.60%

Balance Sheet

Total Cash MRQ	CN¥2,057,898,752
Total Cash per Share MRQ	CN¥5.13
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	16.98
Current Ratio MRQ	1.81
Book Value per Share MRQ	CN¥8.29

Cash Flow

Operating Cash Flow TTM	CN¥390,976,576
Levered Free Cash Flow TTM	CN¥102,505,312

603983 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	401,000,000
Float Shares	77,000,020
Avg 10 Volume	2,274,165
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	80.80%
% Held by Institutions	9.53%

Stock Price Summary

Beta	0.31
Fifty Two Week Low	CN¥29.43
Fifty Two Week High	CN¥56.98
Fifty Two Week Change	4.53%
Day 50 MA	CN¥34.02
Day 200 MA	CN¥39.87

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.00
Forward Annual Dividend Yield	3.02%
Trailing Annual Dividend Rate	CN¥0.25
Trailing Annual Dividend Yield	0.75%
Payout Ratio	87.21%
Dividend Date
Ex Dividend Date	2025-11-14
Last Split Factor
Last Split Date